Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
125 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 69344 |
1949 | 2 | INFLIXIMAB//ETANERCEPT//ADALIMUMAB | 6111 |
757 | 1 | TUMOR NECROSIS FACTOR//TNF RECEPTOR//MORRIS HEPATOMA 5123 | 3121 |
11054 | 1 | TUBERCULIN SKIN TEST//LATENT TUBERCULOSIS INFECTION//INFLIXIMAB | 1040 |
13119 | 1 | METHOTREXATE ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//LYMPHOPROLIFERATIVE DISORDERS//IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS | 890 |
15487 | 1 | INFLIXIMAB//ETANERCEPT//ADALIMUMAB | 737 |
24842 | 1 | PRE LIGAND BINDING ASSEMBLY DOMAIN PLAD//TNFR2//PHARMACEUT PROTE | 323 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | INFLIXIMAB | authKW | 177282 | 5% | 11% | 310 |
2 | ETANERCEPT | authKW | 139283 | 3% | 14% | 197 |
3 | ADALIMUMAB | authKW | 121099 | 3% | 14% | 169 |
4 | TUMOR NECROSIS FACTOR | authKW | 121078 | 5% | 7% | 328 |
5 | RHEUMATOID ARTHRITIS | authKW | 73067 | 9% | 3% | 546 |
6 | TNF RECEPTOR | authKW | 71103 | 1% | 21% | 67 |
7 | RHEUMATOLOGY | WoSSC | 67266 | 19% | 1% | 1174 |
8 | TNF ALPHA ANTAGONISTS | authKW | 63041 | 1% | 37% | 33 |
9 | ANTI TNF | authKW | 51272 | 1% | 14% | 72 |
10 | ANTI TNF ALPHA | authKW | 49576 | 1% | 18% | 55 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Rheumatology | 67266 | 19% | 1% | 1174 |
2 | Immunology | 11690 | 22% | 0% | 1342 |
3 | Oncology | 3435 | 14% | 0% | 864 |
4 | Dermatology | 2166 | 5% | 0% | 305 |
5 | Medicine, Research & Experimental | 1229 | 6% | 0% | 396 |
6 | Cell Biology | 882 | 8% | 0% | 499 |
7 | Biochemistry & Molecular Biology | 790 | 14% | 0% | 848 |
8 | Hematology | 671 | 4% | 0% | 244 |
9 | Gastroenterology & Hepatology | 490 | 3% | 0% | 210 |
10 | Medicine, General & Internal | 421 | 6% | 0% | 340 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | RHEUMATOL | 36741 | 9% | 1% | 554 |
2 | AG LES MARKUS KRANKENHAUS | 15466 | 0% | 100% | 3 |
3 | PHARMACEUT PROTE | 15199 | 0% | 27% | 11 |
4 | TEACHING WARD INTERNAL MED | 11598 | 0% | 75% | 3 |
5 | PATHOL TUMOR IMMUNOL | 11592 | 0% | 38% | 6 |
6 | CH EL ALLERTON HOSP LEEDS | 10311 | 0% | 100% | 2 |
7 | GRP PHARMAKOEPIDEMIOL | 10311 | 0% | 100% | 2 |
8 | INFECT PREVENT CONTROL TB CLIN | 10311 | 0% | 100% | 2 |
9 | RECH EPIDEMIOL STATINSERMU1153 EPIDEM | 10311 | 0% | 100% | 2 |
10 | UNIT MOL PATHOPHYSIOL EXPT THER Y | 10307 | 0% | 50% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LYMPHOKINE AND CYTOKINE RESEARCH | 26815 | 1% | 15% | 35 |
2 | LYMPHOKINE RESEARCH | 18147 | 1% | 11% | 32 |
3 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 11467 | 1% | 7% | 33 |
4 | CLINICAL RHEUMATOLOGY | 10876 | 2% | 2% | 109 |
5 | ANNALS OF THE RHEUMATIC DISEASES | 10506 | 2% | 2% | 137 |
6 | JOURNAL OF INFLAMMATION | 9377 | 0% | 15% | 12 |
7 | MODERN RHEUMATOLOGY | 6256 | 1% | 3% | 41 |
8 | RHEUMATOLOGY INTERNATIONAL | 6255 | 1% | 2% | 76 |
9 | JOURNAL OF CROHNS & COLITIS | 6197 | 1% | 3% | 37 |
10 | JOURNAL OF RHEUMATOLOGY | 5482 | 2% | 1% | 119 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INFLIXIMAB | 177282 | 5% | 11% | 310 | Search INFLIXIMAB | Search INFLIXIMAB |
2 | ETANERCEPT | 139283 | 3% | 14% | 197 | Search ETANERCEPT | Search ETANERCEPT |
3 | ADALIMUMAB | 121099 | 3% | 14% | 169 | Search ADALIMUMAB | Search ADALIMUMAB |
4 | TUMOR NECROSIS FACTOR | 121078 | 5% | 7% | 328 | Search TUMOR+NECROSIS+FACTOR | Search TUMOR+NECROSIS+FACTOR |
5 | RHEUMATOID ARTHRITIS | 73067 | 9% | 3% | 546 | Search RHEUMATOID+ARTHRITIS | Search RHEUMATOID+ARTHRITIS |
6 | TNF RECEPTOR | 71103 | 1% | 21% | 67 | Search TNF+RECEPTOR | Search TNF+RECEPTOR |
7 | TNF ALPHA ANTAGONISTS | 63041 | 1% | 37% | 33 | Search TNF+ALPHA+ANTAGONISTS | Search TNF+ALPHA+ANTAGONISTS |
8 | ANTI TNF | 51272 | 1% | 14% | 72 | Search ANTI+TNF | Search ANTI+TNF |
9 | ANTI TNF ALPHA | 49576 | 1% | 18% | 55 | Search ANTI+TNF+ALPHA | Search ANTI+TNF+ALPHA |
10 | TNF | 48618 | 3% | 6% | 154 | Search TNF | Search TNF |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |